This is the first case of trying to treat Parkinson's disease by injecting stem cells into the brain. Photo: EPA
First, a monkey experiment is carried out
November 9, 2018 at 17:19
Kyoto – MMC RTV SLO, STA
Japanese researchers have introduced stem cells as part of an effort to treat Parkinson's disease in the patient's stem, reports from Kyoto University.
It has been clarified that IPS stem cells, which have the ability to convert to all types of cells in the body, have been introduced to men in their 50s during the surgery they performed in October. The man is stable and will be controlled for two years, reports the AFP news agency, AFP.
On the left side of the brain, 2.4 million iPS stem cells, induced pluripotent stem cells are introduced. The intervention lasted three hours.
If in the next six months the patient does not have a problem, the same number of stem cells will be added to the right side of the brain.
Stem cells obtained from healthy donors have been developed into dopamine-producing brain cell precursors that die in patients with Parkinson's disease, according to the French news agency, AFP.
This is the first case of an attempt to treat Parkinson's disease by injecting stem cells into the brain, according to AFP.
Successful experiments on monkeys
The university conducted an operation after reporting in July that this type of treatment would be tested in seven patients aged between 50 and 69 years. They decided to do this after a successful experiment on monkeys, which, after the introduction of these iPS cells to the brain, significantly improved their motor skills. In two years they have not developed a brain tumor.
Parkinson's disease is a chronic neurodegenerative disease, the cause is unknown. Because of the decay of dopamine neurons in the brain, this disease continues to develop and cannot be fully cured. The main motoric symptoms are slow motion, muscle stiffness, trembling, and balance disorders. Among the many non-motor symptoms are emotional disorders, psychosis, sleep disorders, digestive disorders, and various sensory problems.
In the world, according to the Fund for Parkinson's disease, about 10 million people. There are around 7,000 people with Parkinson's disease in Slovenia.
IPS stem cells are adult stem cells that have been returned to embryonic stem cells through genetic modification.
Report an error